M. Criqui, A. Fronek, E. Barrett-connor, M. Klauber, S. Gabriel et al., The prevalence of peripheral arterial disease in a defined population, Circulation, vol.71, issue.3, pp.510-515, 1985.
DOI : 10.1161/01.CIR.71.3.510

A. Newman, D. Siscovick, T. Manolio, J. Polak, L. Fried et al., Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group, Circulation, vol.88, issue.3, pp.837-882, 1993.
DOI : 10.1161/01.CIR.88.3.837

A. Hirsch, M. Criqui, D. Treat-jacobson, J. Regensteiner, M. Creager et al., Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care, JAMA, vol.286, issue.11, pp.1317-1341, 2001.
DOI : 10.1001/jama.286.11.1317

H. Boccalon, P. Lehert, and M. Mosnier, Appréciation de la prévalence de l'artériopathie oblitérante des membres inférieurs en france à l'aide de l'index systolique dans une population à risque vasculaire, J Mal Vasc, vol.25, issue.1, pp.38-46, 2000.

A. Wood and W. Hiatt, Medical Treatment of Peripheral Arterial Disease and Claudication, New England Journal of Medicine, vol.344, issue.21, pp.1608-1629, 2001.
DOI : 10.1056/NEJM200105243442108

W. Hughson, J. Mann, and A. Garrod, Intermittent claudication: prevalence and risk factors., BMJ, vol.1, issue.6124, pp.1379-81, 1978.
DOI : 10.1136/bmj.1.6124.1379

J. Dormandy and G. Murray, The fate of the claudicant???a prospective study of 1969 claudicants, European Journal of Vascular Surgery, vol.5, issue.2, pp.131-134, 1991.
DOI : 10.1016/S0950-821X(05)80676-0

J. Belch, E. Topol, G. Agnelli, M. Bertrand, R. Califf et al., Critical Issues in Peripheral Arterial Disease Detection and Management<subtitle>A Call to Action</subtitle>, Archives of Internal Medicine, vol.163, issue.8, pp.884-92, 2003.
DOI : 10.1001/archinte.163.8.884

E. Rossi, Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular Disease: Predictive Role of C-Reactive Protein. Circulation, pp.800-803, 2002.

J. Caro, K. Migliaccio-walle, K. Ishak, and I. Proskorovsky, The morbidity and mortality following a diagnosis of peripheral arterial disease: Long-term follow-up of a large database, BMC Cardiovascular Disorders, vol.12, issue.suppl 2, p.14, 2005.
DOI : 10.1007/s11606-006-5042-4

M. Criqui, R. Langer, A. Fronek, H. Feigelson, M. Klauber et al., Mortality over a period of 10 years in patients with peripheral arterial disease. NEJM, Feb, vol.6326, issue.6, pp.381-387, 1992.

E. Jude, S. Oyibo, N. Chalmers, and A. Boulton, Peripheral Arterial Disease in Diabetic and Nondiabetic Patients: A comparison of severity and outcome, Diabetes Care, vol.24, issue.8, pp.1433-1440, 2001.
DOI : 10.2337/diacare.24.8.1433

D. Mukherjee, K. Munir, A. Hirsch, S. Chetcuti, P. Grossman et al., Development of a multicenter peripheral arterial interventional database: The PVD-QI2, American Heart Journal, vol.149, issue.6, 2005.
DOI : 10.1016/j.ahj.2004.08.015

S. Taylor, C. Kalbaugh, D. Blackhurst, E. Langan, D. Cull et al., Postoperative Outcomes According to Preoperative Medical and Functional Status After Infrainguinal Revascularization for Critical Limb Ischemia in Patients 80 Years and Older, Am Surg, vol.71, issue.8, pp.640-646, 2005.

S. Cheng, A. Ting, H. Lau, and J. Wong, Survival in Patients with Chronic Lower Extremity Ischemia: A Risk Factor Analysis, Annals of Vascular Surgery, vol.14, issue.2, pp.158-65, 2000.
DOI : 10.1007/s100169910028

R. Fontaine, M. Kim, and R. Kieny, Surgical treatment of peripheral circulation disorders]. Helv Chir Acta, pp.499-533, 1954.

R. Rutherford, J. Baker, C. Ernst, K. Johnston, J. Porter et al., Recommended standards for reports dealing with lower extremity ischemia: Revised version, Journal of Vascular Surgery, vol.26, issue.3, pp.517-555, 1997.
DOI : 10.1016/S0741-5214(97)70045-4

G. Sanna, D. Alesso, M. Mediati, C. Cimminiello, C. Borghi et al., Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study Data from PANDORA (Prevalence of peripheral Arterial disease in subjects with moderate CVD risk, with No overt vascular Diseases nor Diabetes mellitus), BMC Cardiovascular Disorders, vol.27, issue.Suppl 2, p.59, 2011.
DOI : 10.1093/eurheartj/ehl092

G. Smith, M. Shipley, and G. Rose, Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation, pp.1925-1956, 1990.

C. Cole, G. Hill, E. Farzad, A. Bouchard, D. Moher et al., Cigarette smoking and peripheral arterial occlusive disease. surgery, pp.753-759, 1993.

M. Alzamora, R. Forés, J. Baena-díez, G. Pera, P. Toran et al., The Peripheral Arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population, BMC Public Health, vol.107, issue.1, p.38, 2010.
DOI : 10.1016/j.ijcard.2005.04.005

W. Meijer, A. Hoes, D. Rutgers, M. Bots, A. Hofman et al., Determinants of Peripheral Arterial Disease in the Elderly, Archives of Internal Medicine, vol.160, issue.19, pp.185-92, 1998.
DOI : 10.1001/archinte.160.19.2934

W. Hiatt, S. Hoag, and R. Hamman, Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation, pp.1472-1481, 1995.

E. Selvin, S. Marinopoulos, G. Berkenblit, T. Rami, F. Brancati et al., Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus, Annals of Internal Medicine, vol.141, issue.6, pp.421-452, 2004.
DOI : 10.7326/0003-4819-141-6-200409210-00007

P. Priollet, J. Mourad, P. Cacoub, H. Lévesque, F. Luizy et al., L???art??riopathie des membres inf??rieurs en m??decine g??n??rale. Quelle prise en charge ?, Journal des Maladies Vasculaires, vol.29, issue.5, pp.249-56, 2004.
DOI : 10.1016/S0398-0499(04)96769-8

J. Murabito, J. Evans, K. Nieto, M. Larson, D. Levy et al., Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study, American Heart Journal, vol.143, issue.6, 2002.
DOI : 10.1067/mhj.2002.122871

I. Ingolfsson, G. Sigurdsson, H. Sigvaldason, G. Thorgeirsson, and N. Sigfusson, A marked decline in the prevalence and incidence of intermittent claudication in icelandic men 1968???1986: A strong relationship to smoking and serum cholesterol???The Reykjavik study, Journal of Clinical Epidemiology, vol.47, issue.11, pp.1237-1280, 1994.
DOI : 10.1016/0895-4356(94)90128-7

A. Reunanen, H. Takkunen, and A. Aromaa, Prevalence of Intermittent Claudication and Its Effect on Mortality, Acta Medica Scandinavica, vol.94, issue.4, pp.249-56, 1982.
DOI : 10.1111/j.0954-6820.1982.tb01939.x

N. Khandanpour, Y. Loke, F. Meyer, B. Jennings, and M. Armon, Homocysteine and Peripheral Arterial Disease: Systematic Review and Meta-analysis, European Journal of Vascular and Endovascular Surgery, vol.38, issue.3, pp.316-338, 2009.
DOI : 10.1016/j.ejvs.2009.05.007

P. Ridker, M. Cushman, M. Stampfer, R. Tracy, and C. Hennekens, Plasma Concentration of C- Reactive Protein and Risk of Developing Peripheral Vascular Disease. Circulation, Feb, vol.1097, issue.5, pp.425-433, 1998.

. Medic-'am, A. Arnold, J. Mcauliff, F. Luduena, T. Brown et al., Available from: http://www.ameli.fr/l-assurance-maladie/statistiques-et-publications/donnees- statistiques/medicament/medic-am-2008-2011 Differentiation of receptor systems activated by sympathomimetic amines, Nature, vol.214, pp.597-605, 1967.

S. Bangalore, S. Parkar, E. Grossman, and F. Messerli, A Meta-Analysis of 94,492 Patients With Hypertension Treated With Beta Blockers to Determine the Risk of New-Onset Diabetes Mellitus, The American Journal of Cardiology, vol.100, issue.8
DOI : 10.1016/j.amjcard.2007.05.057

C. Lavie, F. Messerli, and R. Milani, Beta-Blockers as First-Line Antihypertensive Therapy, Journal of the American College of Cardiology, vol.54, issue.13, pp.1162-1166, 2009.
DOI : 10.1016/j.jacc.2009.05.053

L. Lindholm, B. Carlberg, and O. Samuelsson, Should _betablockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet, pp.1545-53, 2005.

C. Wiysonge, H. Bradley, B. Mayosi, R. Maroney, A. Mbewu et al., Beta-blockers for hypertension In: The Cochrane Collaboration, Wiysonge CSU, Cochrane Database Syst Rev [Internet], 2007.

J. Wright and V. Musini, First-line drugs for hypertension, Cochrane Database Syst Rev, 2009.

/. Authors, . Task-force-members, P. Steg, S. James, D. Atar et al., ESC Guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Eur Heart J, vol.33, issue.20, pp.2569-619, 2012.

/. Authors, . Task-force-members, C. Hamm, J. Bassand, S. Agewall et al., ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), Eur Heart J, vol.32, issue.23, pp.2999-3054, 2011.

. Task-force-members, G. Montalescot, U. Sechtem, S. Achenbach, F. Andreotti et al., 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology, Eur Heart J [Internet], 2009.

S. Soumerai, T. Mclauglin, D. Spiegelman, E. Hertzmark, G. Thibault et al., Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction, JAMA: The Journal of the American Medical Association, vol.277, issue.2, pp.115-136, 1997.
DOI : 10.1001/jama.277.2.115

D. Hasdai, A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS), European Heart Journal, vol.23, issue.15, pp.1190-201, 2002.
DOI : 10.1053/euhj.2002.3193

. Hjalmarson-a, D. Elmfeldt, J. Herlitz, S. Holmberg, I. Malek et al., Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial, Lancet, vol.2, issue.8251, pp.823-830, 1981.

H. Dargie, I. Ford, and K. Fox, Total Ischaemic Burden European Trial (TIBET): Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina, European Heart Journal, vol.17, issue.1, pp.104-116, 1996.
DOI : 10.1093/oxfordjournals.eurheartj.a014668

N. Rehnqvist, P. Hjemdahl, E. Billing, I. Björkander, S. Eriksson et al., Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm, Cardiologia, vol.40, issue.12, p.301, 1995.

/. Authors, . Task-force-members, J. Mcmurray, S. Adamopoulos, S. Anker et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC, Eur Heart J, vol.33, issue.14, pp.1787-847, 2012.

M. Komajda, The EuroHeart Failure Survey programme???a survey on the quality of care among patients with heart failure in Europe Part 2: treatment, European Heart Journal, vol.24, issue.5, pp.464-74, 2003.
DOI : 10.1016/S0195-668X(02)00700-5

S. Paravastu, D. Mendonca, D. Silva, and A. , Beta blockers for peripheral arterial disease, Cochrane Database Syst Rev [Internet]. Chichester, 2008.

K. Radack and C. Deck, Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials, Archives of Internal Medicine, vol.151, issue.9, p.1769, 1991.
DOI : 10.1001/archinte.151.9.1769

U. Thadani and T. Whitsett, ??-Adrenergic Blockers and Intermittent Claudication, Archives of Internal Medicine, vol.151, issue.9, pp.1705-1712, 1991.
DOI : 10.1001/archinte.1991.00400090007001

R. Miyajima, K. Sano, and H. Yoshida, ??-Adrenergic Blocking Agents and Intermittent Claudication: Systematic Review, YAKUGAKU ZASSHI, vol.124, issue.11, pp.825-856, 2004.
DOI : 10.1248/yakushi.124.825

W. Aronow and C. Ahn, Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease, The American Journal of Cardiology, vol.87, issue.11, pp.1284-1290, 2001.
DOI : 10.1016/S0002-9149(01)01521-1

D. Bhatt, P. Steg, E. Ohman, A. Hirsch, Y. Ikeda et al., International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis, JAMA, vol.295, issue.2, pp.180-189, 2006.
DOI : 10.1001/jama.295.2.180

J. Blacher, P. Cacoub, F. Luizy, J. Mourad, H. Levesque et al., Peripheral arterial disease versus other localizations of vascular disease: The ATTEST study, Journal of Vascular Surgery, vol.44, issue.2, 2006.
DOI : 10.1016/j.jvs.2006.04.002

E. Béraut, J. Cambou, J. Guilhem, N. Vaysse, S. Labro et al., Traitement m??dical du patient atteint d???art??riopathie ath??roscl??reuse des membres inf??rieurs symptomatique ?? sa sortie de l???h??pital??: ad??quation aux recommandations et ??volution des pratiques dans le temps (registre COPART I), Journal des Maladies Vasculaires, vol.33, issue.1, pp.1-11, 2008.
DOI : 10.1016/j.jmv.2007.09.005

C. Diehm, Association of low ankle brachial index with high mortality in primary care, European Heart Journal, vol.27, issue.14, pp.1743-1752, 2006.
DOI : 10.1093/eurheartj/ehl092

P. Cacoub, J. Cambou, S. Kownator, J. Belliard, J. Beregi et al., Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study, International Journal of Clinical Practice, vol.29, issue.Suppl, pp.63-70, 2009.
DOI : 10.1111/j.1742-1241.2008.01953.x

H. Autorité and D. Santé, Fiche de bon usage des médicaments: Les inhibiteurs du système rénine-angiotensine dans l'HTA exxentielle non compliquée. Comment choisir entre IEC et SARTANS?, 2008.

C. Steering and C. , A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, vol.348, pp.1329-1368, 1996.

H. Feringa, S. Karagiannis, V. Van-waning, E. Boersma, O. Schouten et al., The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease, Journal of Vascular Surgery, vol.45, issue.5, pp.936-979, 2007.
DOI : 10.1016/j.jvs.2007.01.024

M. Mcdermott, Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial Disease. Circulation, pp.757-61, 2003.

P. Cacoub, U. Zeymer, T. Limbourg, I. Baumgartner, D. Poldermans et al., Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe, Heart, vol.97, issue.8, pp.660-667, 2011.
DOI : 10.1136/hrt.2010.213710

S. Spronk, J. Bosch, P. Hoed, H. Veen, P. Pattynama et al., Intermittent Claudication: Clinical Effectiveness of Endovascular Revascularization versus Supervised Hospital-based Exercise Training???Randomized Controlled Trial, Radiology, vol.250, issue.2, pp.586-95, 2009.
DOI : 10.1148/radiol.2501080607

M. Whyman, F. Fowkes, E. Kerracher, I. Gillespie, A. Lee et al., Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial, Journal of Vascular Surgery, vol.26, issue.4, pp.551-558, 1997.
DOI : 10.1016/S0741-5214(97)70052-1

T. Murphy, D. Cutlip, J. Regensteiner, E. Mohler, D. Cohen et al., Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease: Six-Month Outcomes From the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Study. Circulation, pp.130-139, 2011.

A. Bradbury, C. Ruckley, F. Fowkes, J. Forbes, I. Gillespie et al., Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial, Lancet, vol.366, issue.9501, pp.1925-1959, 2005.

P. Lawrence and A. Chandra, When should Open Surgery be the Initial Option for Critical Limb Ischaemia?, European Journal of Vascular and Endovascular Surgery, vol.39, pp.32-37, 2010.
DOI : 10.1016/j.ejvs.2009.11.032

G. Leng, A. Lee, F. Fowkers, M. Whiteman, J. Dunbar et al., Incidence, Natural History and Cardiovascular Events in Symptomatic and Asymptomatic Peripheral Arterial Disease in the General Population, International Journal of Epidemiology, vol.25, issue.6, pp.1172-81, 1996.
DOI : 10.1093/ije/25.6.1172

A. Høgh, The use of secondary prevention after primary vascular reconstruction: Studies on effectiveness, Dan Med J, vol.59, issue.9, p.4514, 2012.

V. Aboyans, E. Ho, J. Denenberg, L. Ho, L. Natarajan et al., The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects, Journal of Vascular Surgery, vol.48, issue.5, pp.1197-203, 2008.
DOI : 10.1016/j.jvs.2008.06.005

V. Bertele, M. Roncaglioni, . Pangrazzi-j, E. Terzian, and G. Tognoni, Clinical Outcome and its Predictors in 1560 Patients with Critical Leg Ischaemia, European Journal of Vascular and Endovascular Surgery, vol.18, issue.5, pp.401-411, 1999.
DOI : 10.1053/ejvs.1999.0934

C. Narins, W. Zareba, A. Moss, V. Marder, P. Ridker et al., Relationship Between Intermittent Claudication, Inflammation, Thrombosis, and Recurrent Cardiac Events Among Survivors of Myocardial Infarction, Archives of Internal Medicine, vol.164, issue.4, p.440, 2004.
DOI : 10.1001/archinte.164.4.440

A. Webb and P. Rothwell, Effect of Dose and Combination of Antihypertensives on Interindividual Blood Pressure Variability: A Systematic Review, Stroke, vol.42, issue.10, pp.2860-2865, 2011.
DOI : 10.1161/STROKEAHA.110.611566

O. Hare and A. , Mortality and Cardiovascular Risk Across the Ankle-Arm Index Spectrum: Results From the Cardiovascular Health Study. Circulation, pp.388-93, 2006.

M. Criqui, R. Mcclelland, M. Mcdermott, M. Allison, R. Blumenthal et al., The Ankle-Brachial Index and Incident Cardiovascular Events in the MESA (Multi-Ethnic Study of Atherosclerosis), Journal of the American College of Cardiology, vol.56, issue.18, pp.1506-1518, 2010.
DOI : 10.1016/j.jacc.2010.04.060

URL : https://hal.archives-ouvertes.fr/hal-00677235

C. Doubeni, R. Yood, S. Emani, and J. Gurwitz, Identifying unrecognized peripheral arterial disease among asymptomatic patients in the primary care setting. angiology, pp.171-80, 2006.

A. Aha, Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). Circulation, pp.463-465, 2005.